Israel - English - Ministry of Health

medison pharma ltd - ivabradine as hydrochloride - film coated tablets - ivabradine as hydrochloride 7.5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Israel - English - Ministry of Health

medison pharma ltd - ivabradine as hydrochloride - film coated tablets - ivabradine as hydrochloride 5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

European Union - English - EMA (European Medicines Agency)

les laboratoires servier - ivabradine hydrochloride - angina pectoris; heart failure - cardiac therapy - symptomatic treatment of chronic stable angina pectoris ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. ivabradine is indicated :in adults unable to tolerate or with a contraindication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.treatment of chronic heart failure ivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - ivabradine adipate - film coated tablet - 5 milligram - other cardiac preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - ivabradine adipate - film coated tablet - 7.5 milligram - other cardiac preparations

Canada - English - Health Canada

servier canada inc - ivabradine (ivabradine hydrochloride) - tablet - 5mg - ivabradine (ivabradine hydrochloride) 5mg - miscellaneous cardiac drugs

Canada - English - Health Canada

servier canada inc - ivabradine (ivabradine hydrochloride) - tablet - 7.5mg - ivabradine (ivabradine hydrochloride) 7.5mg - miscellaneous cardiac drugs

Malta - English - Malta Medicines Authority

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - carvedilol, ivabradine hydrochloride - film-coated tablet - carvedilol 6.25 mg ivabradine hydrochloride 5.390 mg - beta blocking agents

Malta - English - Malta Medicines Authority

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - carvedilol, ivabradine hydrochloride - film-coated tablet - carvedilol 6.25 mg ivabradine hydrochloride 8.085 mg - beta blocking agents

Malta - English - Malta Medicines Authority

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - carvedilol, ivabradine hydrochloride - film-coated tablet - carvedilol 12.5 mg ivabradine hydrochloride 5.390 mg - beta blocking agents